Navigation Links
Control gene for 'conveyor belt' cells could help improve oral vaccines, treat intestinal disease
Date:6/17/2012

Scientists have found a master regulator gene needed for the development of M cells, a mysterious type of intestinal cell involved in initiating immune responses.

M cells act like "conveyor belts," ingesting bacteria and transporting substances from the gut into Peyer's patches, specialized tissues resembling lymph nodes in the intestines. Better knowledge of M cells' properties could aid research on oral vaccines and inflammatory bowel diseases.

A team of researchers at Emory University School of Medicine and RIKEN Research Center for Allergy and Immunology in Japan has identified the gene Spi-B as responsible for the differentiation of M cells.

The results are published Sunday, June 17 in the journal Nature Immunology.

"This discovery could really unlock a lot of information about the sequence of events needed for M cells to develop and what makes them distinctive," says co-author Ifor Williams, MD, PhD, associate professor of pathology and laboratory medicine at Emory University School of Medicine. "M cells have been difficult to study because they are relatively rare, they are only found within the Peyer's patches and can't be grown in isolation."

Scientists at RIKEN, led by senior author Hiroshi Ohno, MD, PhD, teamed up with Williams' laboratory, taking advantage of a discovery by Williams that a protein called RANKL, which is produced by cells in Peyer's patches, can induce M cell differentiation. Research scientist Takashi Kanaya is first author of the paper.

Kanaya and colleagues found that the gene Spi-B is turned on strongly at early stages of M cell differentiation induced by RANKL. Their suspicion of Spi-B's critical role was confirmed when they discovered that mice lacking Spi-B do not have functional M cells, and the cells in the intestines lack several other markers usually found on M cells.

"It was somewhat surprising to find Spi-B expressed in intestinal epithelial cells," Williams says. "Because Spi-B is known to be important for the development of some types of immune cells, it was thought to be expressed only in bone marrow-derived cells."

In fact, the M cells in Spi-B deficient mice can't be restored by a transplant of normal bone marrow, the researchers found. That means Spi-B has to be active in intestinal epithelial cells (not immune cells) for M cells to develop.

Williams says information about M cells in particular, what molecules they have on their surfaces could be useful for targeting oral vaccines. Most vaccines in use today are administered by injection. But immunologists believe that in some cases, it may be better to deliver vaccines through the mouth or nose, thus strengthening the body's defenses where an infection starts.

Because M cells are involved in the uptake of bacteria, the study of M cells could also guide development of treatments for inflammatory bowel diseases, in which immune responses to intestinal bacteria appear to become dysregulated.


'/>"/>
Contact: Quinn Eastman
qeastma@emory.edu
404-727-7829
Emory University
Source:Eurekalert

Related medicine news :

1. Control of disease activity and biologic treatment increase life expectency in RA patients
2. Exercise Controls Weight in White Girls Better Than in Black Girls: Study
3. Tight Blood-Sugar Control Shows Mixed Results for Health of Kidneys: Study
4. Aggressively controlling glucose levels may not reduce kidney failure in Type 2 diabetes
5. Birth Control Pills, HRT Tied to Digestive Ills
6. Lenalidomide prolongs disease control for multiple myeloma patients after stem cell transplant
7. Novel drug candidates offer new route to controlling inflammation
8. Sooner Is Better for Controlling Obese Kids Weight: Study
9. MSU plan would control deadly tsetse fly
10. Control of gene expression: Histone occupancy in your genome
11. Guidelines say diet, exercise, weight control improve odds after cancer diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2020)... ... July 10, 2020 , ... ... announce its newest offering, Liposuction 360 . The group, with offices located ... comprehensive catalog of plastic surgeries and cosmetic procedures is an exciting new addition ...
(Date:7/10/2020)... ... July 09, 2020 , ... CellTrak, the ... health announces that Ohio Department of Medicaid has awarded CellTrak Phase 2 EVV ... in Ohio already rely on CellTrak for EVV – both as a point-of-care ...
(Date:7/10/2020)... ... , ... Ziegler, a specialty investment bank, is pleased to announce the successful ... at Eastgate (Beacon Hill). The Series 2020 Bank Bonds include a $9,800,000 long-term ... that will be retired with initial entrance fees from the Project (detailed below). ...
(Date:7/10/2020)... , ... July 10, 2020 , ... Traliant, an innovator ... a new training course for managers on the Family and Medical Leave Act (FMLA), ... paid sick and family leave provisions related to COVID-19. , For more ...
(Date:7/7/2020)... ... ... Mediaplanet recently launched an awareness initiative to inspire more people to pursue a ... spotlight and, as a result, the Bureau of Labor Statistics predicts job growth of ... — which offers a Master’s in Public Health degree program both online and ...
Breaking Medicine News(10 mins):
(Date:7/10/2020)... CANCUN, Mexico (PRWEB) , ... July 10, 2020 ... ... in Latin America , with 25 years of experience and more than 12 ... Cares'. As its name implies, it promotes care and attention in all facets ...
(Date:7/7/2020)... ... July 07, 2020 , ... ... partnership with Psych Hub, the leading comprehensive platform for online education on mental ... offer support resources to Substance Use Disorder (SUD) patients throughout each step of ...
(Date:7/7/2020)... ... July 07, 2020 , ... SupplyPro announces a Contact Tracing function available ... affecting every one of us. SupplyPro is dedicated to supporting the worldwide response to ... Tracing Report - a powerful tool in the fight against the spread of COVID-19. ...
Breaking Medicine Technology: